Comparing two drugs to control river blindness and other neglected diseases
Treatments studied
Part of Infections, Skin clinical trials.
This trial tests if moxidectin works better than ivermectin for controlling river blindness and other neglected tropical diseases. Both drugs are given as a single dose during mass treatment campaigns in villages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in a village selected for the treatment program
- You can take one of the two study drugs (ivermectin or moxidectin) based on your age and health
- You are not allergic to ivermectin or moxidectin
- You are not pregnant and (if in the moxidectin group) not planning to become pregnant in the next 3 months
- You are not currently hospitalized or too sick to get out of bed
- You are not taking part in another clinical trial at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different medicine combinations given to entire communities to treat and prevent lymphatic filariasis (a parasitic infection that causes swelling). The goal is to find a better way to deliver these medicines to reduce the disease in affected areas.
This study tests whether giving preventive medicine to people who move or migrate can help control river blindness and lymphatic filariasis. It focuses on children and household heads who have missed past treatment rounds.
This trial tests how safe and effective a combined albendazole and ivermectin pill is for treating parasitic infections. It is for school-aged children in specific areas of Ghana and Kenya.
This trial tests whether a combination of medicines works better than a single medicine to treat common intestinal worms (like hookworm and roundworm) in young children in Bangladesh. It is for children who are either stunted (shorter than average for their age) or healthy, and who have a confirmed worm infection.
This Phase 3 trial tests whether giving malaria medicine to people in high-risk households (a “mass drug administration” campaign) can stop local relapses and eliminate vivax malaria. If you live close to a recent malaria case, you may be offered a preventive dose, based on age and medical safety checks.
This study aims to find the best way to treat or prevent malaria in children with HIV. It may also help children without HIV who live in areas where malaria is common.
Hear when a new Onchocerciasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.